Canadian guideline for Parkinson disease
Open accessAbstract
[See related article at [www.cmaj.ca/lookup/doi/10.1503/cmaj.191089][2]][2] KEY POINTS Parkinson disease is chronic and progressive in nature, decreasing the quality of life for both patients with the disease and their caregivers and placing an onerous economic burden on society.[1][2] The first
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Only a few drugs are available for AD and PD, and they can only relieve symptoms but fail to halt the progression of the diseases.
“With the advent of an aging population, more and more people are suffering from AD and PD, but only a few drugs are available for the two diseases mentioned above, and they can only relieve symptoms but fail to halt the progression of the diseases (Du et al. 2018; Grimes et al. 2019).”
From Therapeutic effect of GLP-1 engineered strain on mice model of Alzheimer’s disease and Parkinson’s disease (2020) · cites this paper as Grimes et al. 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048 · see citing works
Shea, B. J., Reeves, B. C., Wells, G., Thuku, M., Hamel, C., Moran, J., Moher, D., Tugwell, P., Welch, V., Kristjansson, E., et al. (2017) · BMJ · doi:10.1136/bmj.j4008 · Cited by 10,636 · see citing works
MDS clinical diagnostic criteria for Parkinson’s disease
Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., et al. (2015) · Movement Disorders · doi:10.1002/mds.26424 · Cited by 7,653 · see citing works
Self-citationCochrane Handbook for Systematic Reviews of Interventions
Higgins, J. P. T., Green, S., & Ben Van Den, A. (2020) · International Coaching Psychology Review · doi:10.53841/bpsicpr.2020.15.2.123 · Cited by 5,670 · see citing works
AGREE II: advancing guideline development, reporting and evaluation in health care
Brouwers, M. C., Kho, M. E., Browman, G. P., Burgers, J. S., Cluzeau, F., Feder, G., Fervers, B., Graham, I. D., Grimshaw, J., Hanna, S. E., et al. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.090449 · Cited by 3,790 · see citing works
Seppi, K., Weintraub, D., Coelho, M., Perez‐Lloret, S., Fox, S. H., Katzenschlager, R., Hametner, E., Poewe, W., Rascol, O., Goetz, C. G., et al. (2011) · Movement Disorders · doi:10.1002/mds.23884 · Cited by 1,141 · see citing works
Self-citationAGREE II: advancing guideline development, reporting, and evaluation in health care
Brouwers, M. C., Kho, M. E., Browman, G. P., Burgers, J. S., Cluzeau, F., Feder, G., Fervers, B., Graham, I. D., Grimshaw, J., Hanna, S. E., et al. (2010) · Preventive Medicine · doi:10.1016/j.ypmed.2010.08.005 · Cited by 758 · see citing works
AGREE II: Advancing guideline development, reporting and evaluation in health care
Brouwers, M. C., Kho, M. E., Browman, G. P., Burgers, J. S., Cluzeau, F., Feder, G., Fervers, B., Graham, I. D., Grimshaw, J., Hanna, S. E., et al. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.001 · Cited by 563 · see citing works
Fox, S. H., Katzenschlager, R., Lim, S., Ravina, B. M., Seppi, K., Coelho, M. M., Poewe, W. H., Rascol, O., Goetz, C. G., & Sampaio, C. (2011) · Movement Disorders · doi:10.1002/mds.23829 · Cited by 523 · see citing works
Self-citationPahwa, R., Factor, S. A., Lyons, K. E., Ondo, W. G., Gronseth, G., Bronte-Stewart, H. M., Hallett, M., Miyasaki, J. M., Stevens, J. C., & Weiner, W. J. (2006) · Neurology · doi:10.1212/01.wnl.0000215250.82576.87 · Cited by 500 · see citing works
Self-citationFerreira, J. J., Katzenschlager, R., Bloem, B. R., Bonuccelli, U., Burn, D. J., Deuschl, G., Dietrichs, E., Fabbrini, G., Friedman, A., Kaňovský, P., et al. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2012.03866.x · Cited by 359 · see citing works
Postuma, R. B., Iranzo, Á., Högl, B., Arnulf, I., Ferini‐Strambi, L., Manni, R., Miyamoto, T., Oertel, W. H., Dauvilliers, Y. A., Ju, Y. S., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24385 · Cited by 290 · see citing works
Self-citationLongitudinal analysis of impulse control disorders in Parkinson disease
Corvol, J.-C., Artaud, F., Cormier-Dequaire, F., Rascol, O., Durif, F., Derkinderen, P., Marques, A.-R., Bourdain, F., Brandel, J.-P., Pico, F., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000005816 · Cited by 253 · see citing works
Supplement 4: Canadian Guidelines on Parkinson's Disease
Grimes, D., Gordon, J., Snelgrove, B., Lim-Carter, I., Fon, E. A., Martin, W. R. W., Wieler, M., Suchowersky, O., Rajput, A. H., Lafontaine, A. L., et al. (2012) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s031716710001516x · Cited by 124 · see citing works
Self-citationParkinson's disease: Prevalence, diagnosis and impact.
Wong, S. L., Gilmour, H., & Ramage-Morin, P. L. (2014) · PubMed · Cited by 101 · see citing works
Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease
Renoux, C., Dell’Aniello, S., Khairy, P., Marras, C., Bugden, S., Turin, T. C., Blais, L., Tamim, H., Evans, C. D., Steele, R. J., et al. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12964 · Cited by 43 · see citing works
Late (Complicated) Parkinson's Disease
Oertel, W. H., Berardelli, A., Bloem, B. R., Bonuccelli, U., Burn, D. J., Deuschl, G., Dietrichs, E., Fabbrini, G., Ferreira, J. J., Friedman, A., et al. (2010) · Wiley eBooks · doi:10.1002/9781444328394.ch15 · Cited by 28 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Zhou, X., Lu, J., Wei, K., Wei, J., Tian, P., Yue, M., Wang, Y., Hong, D., Li, F., Wang, B., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9424582 · Cited by 85 · see citing works
Fang, X., Zhou, X., Miao, Y., Han, Y., Wei, J., & Chen, T. (2020) · AMB Express · doi:10.1186/s13568-020-01014-6 · Cited by 70 · see citing works
- Authors
- Grimes, D., Fitzpatrick, M., Gordon, J., Miyasaki, J., Fon, E. A., Schlossmacher, M., Suchowersky, O., Rajput, A., Lafontaine, A. L., Mestre, T., Appel-Cresswell, S., Kalia, S. K., Schoffer, K., Zurowski, M., Postuma, R. B., Udow, S., Fox, S., Barbeau, P., & Hutton, B.
- Affiliations
- Dalhousie University (CA)
- ORCID
- Venue
- Canadian Medical Association Journal
- Publisher
- CMA Impact Inc.
- Published
- 2019-09-08
- Volume
- 191
- Issue
- 36
- Pages
- E989-E1004
- ISSN
- 0820-3946 (ISSN-L)
- 1488-2329
- PMC
- PMC6733687
- OpenAlex
- W2971709044
- Cited by
- 173
- References
- 17
- Citations by year
- 2026: 12 · 2025: 34 · 2024: 28 · 2023: 29 · 2022: 24 · 2021: 32 · 2020: 13 · 2019: 1
- FWCI
- 11.84
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Canadian Medical Association Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship@McGill (McGill) (submittedVersion)
- Funders
- Parkinson Canada
- Topics
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Health Sciences › Medicine › Neurology › Neurological disorders and treatments
- Keywords
- Parkinson's disease, diagnosis, treatment, quality of life, caregiver burden, economic burden
- MeSH terms
- Decision Making, Shared, Canada, Exercise Therapy, Humans, Palliative Care, Parkinson Disease, Patient Education as Topic, Policy Making, Quality of Life, Disease Progression, Dopamine Agonists, Deep Brain Stimulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
